News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

With deCODE genetics, Inc. (DCGN) Deal, Amgen (AMGN) Aims to Discover Drugs Like We Meant to in 1999


12/11/2012 8:50:21 AM

It certainly wasn’t the deal Amgen investors were expecting from their new executive team: This morning, the Thousand Oaks, Calif., biotechnology giant dropped $415 million on DeCode Genetics, a genomics firm that Wall Streeters associate with the hype-filled days of the 2000s genomics boom and a company they probably hadn’t thought about since it went bankrupt in 2010.

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES